Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1956
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 2
1960 1
1962 1
1963 1
1964 2
1967 1
1969 1
1970 1
1971 5
1972 1
1977 1
1979 3
1980 1
1984 1
1985 2
1987 2
1988 3
1989 4
1990 3
1991 7
1992 1
1993 3
1994 2
1996 1
1997 1
1998 2
2000 2
2001 1
2002 1
2004 1
2008 6
2009 2
2010 1
2011 3
2012 3
2013 9
2014 3
2015 5
2016 11
2017 6
2018 3
2019 6
2020 4
2021 4
2022 7
2023 8
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
A Tissue-Engineered Construct Based on a Decellularized Scaffold and the Islets of Langerhans: A Streptozotocin-Induced Diabetic Model.
Sevastianov VI, Ponomareva AS, Baranova NV, Belova AD, Kirsanova LA, Nikolskaya AO, Kuznetsova EG, Chuykova EO, Skaletskiy NN, Skaletskaya GN, Nemets EA, Basok YB, Gautier SV. Sevastianov VI, et al. Among authors: belova ad. Life (Basel). 2024 Nov 19;14(11):1505. doi: 10.3390/life14111505. Life (Basel). 2024. PMID: 39598303 Free PMC article.
Modeling neurodegenerative disorders in zebrafish.
Bashirzade AA, Zabegalov KN, Volgin AD, Belova AS, Demin KA, de Abreu MS, Babchenko VY, Bashirzade KA, Yenkoyan KB, Tikhonova MA, Amstislavskaya TG, Kalueff AV. Bashirzade AA, et al. Among authors: belova as. Neurosci Biobehav Rev. 2022 Jul;138:104679. doi: 10.1016/j.neubiorev.2022.104679. Epub 2022 Apr 28. Neurosci Biobehav Rev. 2022. PMID: 35490912 Review.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Decellularized Umbilical Cord as a Scaffold to Support Healing of Full-Thickness Wounds.
Kondratenko AA, Tovpeko DV, Volov DA, Kalyuzhnaya LI, Chernov VE, Glushakov RI, Sirotkina MY, Zemlyanoy DA, Bildyug NB, Chebotarev SV, Alexander-Sinclair EI, Nashchekin AV, Belova AD, Grigoriev AM, Kirsanova LA, Basok YB, Sevastianov VI. Kondratenko AA, et al. Among authors: belova ad. Biomimetics (Basel). 2024 Jul 3;9(7):405. doi: 10.3390/biomimetics9070405. Biomimetics (Basel). 2024. PMID: 39056846 Free PMC article.
A Low-Cost Protocol Using the Adjunctive Action of Povidone-Iodine Irrigations and Sodium Hypochlorite Rinsing Solution in Step 2 of Periodontal Therapy for Patients with Stage III-IV Periodontitis: A Single-Blind, Randomized Controlled Trial.
Kardaras G, Christodorescu R, Boariu M, Rusu D, Belova A, Chinnici S, Vela O, Radulescu V, Boia S, Stratul SI. Kardaras G, et al. Among authors: belova a. Dent J (Basel). 2024 May 15;12(5):144. doi: 10.3390/dj12050144. Dent J (Basel). 2024. PMID: 38786542 Free PMC article.
147 results